324
M. Zahid et al. / Free Radical Biology & Medicine 48 (2010) 318–324
compared the reaction of the catechol quinone of benzene, CAT-Q,
with dG or DNA to that of the catechol quinone of NADA, NADA-Q.
Reaction of the quinones with dG forms N7dG adducts that slowly
lose the deoxyribose moiety to form N7Gua adducts. We have
investigated the kinetics of this loss of the deoxyribose moiety for
both CAT-4-N7dG and NADA-6-N7dG at pH 4 (Figs. 5 and 6) and
observed the rate of disappearance of the N7dG adducts with
formation of the N7Gua adducts. The conversion of the CAT-4-N7dG
adduct to the N7Gua adduct had a half-life of approximately 3 h
(Fig. 5), whereas the conversion of the NADA-6-N7dG adduct had a
half-life of approximately 4 h (Fig. 6).
A further comparison of CAT-Q and NADA-Q was obtained by
reaction of the quinones with DNA at pH 4. With DNA, it was
observed that the CAT-4-N3Ade and NADA-6-N3Ade adducts were
formed and lost from DNA instantaneously, whereas the N7Gua
adducts were lost more slowly, with half-lives of approximately 3 h
(Figs. 7 and 8). With CAT-Q, the amount of the N3Ade adducts was
more than twice that of the N7Gua adduct after 10 h (Fig. 7). In
contrast, NADA-Q formed almost equal amounts of the N3Ade and
N7Gua adducts in 10 h (Fig. 8).
Finally, the formation of N3Ade and N7Gua adducts by reaction of
CAT-Q with DNA was studied at pH 4 to 7 (Fig. 9A). The maximum yield
of both adducts was observed at pH 4, whereas at pH 7 the yield was
negligible. In contrast, when tyrosinase-activated CAT was reacted with
DNA atpH 5 to 8 (Fig. 9B), the amounts of the N3Ade and N7Gua adducts
were about the same. The highest yield was at pH 5 and the yield
decreased as the pH increased. The amounts of the adducts were much
larger than those obtained from the reaction of the CAT-Q with DNA. For
example, at pH 5, the amounts of the adducts obtained from tyrosinase-
activated CAT were at least 10 times higher than those obtained with
CAT-Q (Figs. 9A and 9B). This is presumably due to the instability of the
quinone and the efficient reaction of the catechol after intercalation in
the DNA and activation to quinone by tyrosinase. This mechanism has
been demonstrated with the catechol of diethylstilbestrol [8].
When formation of N3Ade and N7Gua adducts by reaction of
NADA-Q with DNA was studied at pH 4 to 7 (Fig. 10A), the maximum
yield of both adducts was observed at pH 4 and decreased as the pH
rose from 5 to 7. Both adducts were observed at similar levels at all pH.
When NADA was activated by tyrosinase to react with DNA at pH 5 to
8, the amounts of adducts were at least 15 times higher than after the
direct reaction of NADA-Q with DNA (Fig. 10B). Again, this is
presumably due to the instability of NADA-Q and the efficient reaction
of NADA after intercalation into the DNA and activation to NADA-Q by
tyrosinase. The levels of the N3Ade and N7Gua adducts were not
significantly different from each other.
References
[1] Cavalieri, E.; Chakravarti, D.; Guttenplan, J.; Hart, E.; Ingle, J.; Jankowiak, R.; Muti,
P.; Rogan, E.; Russo, J.; Santen, R.; Sutter, T. Catechol estrogen quinones as
initiators of breast and other human cancers: implications for biomarkers of
susceptibility and cancer prevention. Biochim. Biophys. Acta 1766:63–78; 2006.
[2] Cavalieri, E.; Rogan, E. Catechol quinones of estrogens in the initiation of breast,
prostate, and other human cancers: keynote lecture. Ann. N. Y. Acad. Sci. 1089:
286–301; 2006.
[3] Stack, D. E.; Li, G.; Hill, A.; Hoffman, N. Mechanistic insights into the Michael
addition of deoxyguanosine to catechol estrogen-3,4-quinones. Chem. Res. Toxicol.
21:1415–1425; 2008.
[4] Chakravarti, D.; Mailander, P. C.; Li, K. M.; Higginbotham, S.; Zhang, H. L.; Gross,
M. L.; Meza, J. L.; Cavalieri, E. L.; Rogan, E. G. Evidence that a burst of DNA
depurination in SENCAR mouse skin induces error-prone repair and forms
mutations in the H-ras gene. Oncogene 20:7945–7953; 2001.
[5] Mailander, P. C.; Meza, J. L.; Higginbotham, S.; Chakravarti, D. Induction of A.T to
G.C mutations by erroneous repair of depurinated DNA following estrogen
treatment of the mammary gland of ACI rats. J. Steroid Biochem. Mol. Biol. 101:
204–215; 2006.
[6] Saeed, M.; Zahid, M.; Gunselman, S. J.; Rogan, E.; Cavalieri, E. Slow loss of
deoxyribose from the N7deoxyguanosine adducts of estradiol-3,4-quinone and
hexestrol-3′,4′-quinone: implications for mutagenic activity. Steroids 70:29–35;
2005.
[7] Saeed, M.; Gunselman, S. J.; Higginbotham, S.; Rogan, E.; Cavalieri, E. Formation of
the depurinating N3adenine and N7guanine adducts by reaction of DNA with
hexestrol-3′,4′-quinone or enzyme-activated 3′-hydroxyhexestrol: implications
for a unifying mechanism of tumor initiation by natural and synthetic estrogens.
Steroids 70:37–45; 2005.
[8] Saeed, M.; Rogan, E.; Cavalieri, E. Mechanism of metabolic activation and DNA
adduct formation by the human carcinogen diethylstilbestrol: the defining link to
natural estrogens. Int. J. Cancer 124:1276–1284; 2009.
[9] Saeed, M.; Higginbotham, S.; Rogan, E.; Cavalieri, E. Formation of depurinating
N3adenine and N7guanine adducts after reaction of 1,2-naphthoquinone or
enzyme-activated 1,2-dihydroxynaphthalene with DNA: implications for the
mechanism of tumor initiation by naphthalene. Chem. Biol. Interact. 165:175–188;
2007.
[10] Saeed, M.; Higginbotham, S.; Gaikwad, N.; Chakravarti, D.; Rogan, E.; Cavalieri, E.
Depurinating naphthalene–DNA adducts in mouse skin related to cancer
initiation. Free Radic. Biol. Med. 47:1075–1081; 2009.
[11] Cavalieri, E. L.; Li, K. M.; Balu, N.; Saeed, M.; Devanesan, P.; Higginbotham, S.; Zhao,
J.; Gross, M. L.; Rogan, E. G. Catechol ortho-quinones: the electrophilic compounds
that form depurinating DNA adducts and could initiate cancer and other diseases.
Carcinogenesis 23:1071–1077; 2002.
[12] Snyder, R.; Kalf, G. F. A. perspective on benzene leukemogenesis. Crit. Rev. Toxicol.
24:177–209; 1994.
[13] Guengerich, F. P.; Kim, D. H.; Iwasaki, M. Role of human cytochrome P-450 IIE1 in
the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol. 4:
168–179; 1991.
[14] Sabourin, P. J.; Bechtold, W. E.; Griffith, W. C.; Birnbaum, L. S.; Lucier, G.;
Henderson, R. F. Effect of exposure concentration, exposure rate, and route of
administration on metabolism of benzene by F344 rats and B6C3F1 mice. Toxicol.
Appl. Pharmacol. 99:421–444; 1989.
[15] Kalf, G. F. Recent advances in the metabolism and toxicity of benzene. Crit. Rev.
Toxicol. 18:141–159; 1987.
[16] Levay, G.; Pongracz, K.; Bodell, W. J. Detection of DNA adducts in HL-60 cells treated
with hydroquinone and p-benzoquinone by 32P-postlabeling. Carcinogenesis 12:
1181–1186; 1991.
[17] Levay, G.; Ross, D.; Bodell, W. J. Peroxidase activation of hydroquinone results in
the formation of DNA adducts in HL-60 cells, mouse bone marrow macrophages
and human bone marrow. Carcinogenesis 14:2329–2334; 1993.
[18] Twerdok, L. E.; Trush, M. A. Differences in quinone reductase activity in primary
bone marrow stromal cells derived from C57BL/6 and DBA/2 mice. Res. Commun.
Chem. Pathol. Pharmacol. 67:375–386; 1990.
The catechol quinones of natural [20–22] and synthetic [6–8]
estrogens, benzene [11], naphthalene [9,10], and dopamine [11] react
with DNA by 1,4-Michael addition to form predominantly depurinat-
ing N3Ade and N7Gua adducts. With all of these compounds, the
N3Ade adduct depurinates instantaneously from DNA, whereas the
N7Gua adduct depurinates slowly, with a half-life of a few hours.
These common features may lead to the initiation of cancer or
neurodegenerative disease.
[19] Huang, X.; Xu, R.; Hawley, M. D.; Kramer, K. J. Model insect cuticle sclerotization:
reactions of catecholamine quinones with the nitrogen-centered nucleophiles
imidazole and N-acetylhistidine. Bioorg. Chem. 25:179–202; 1997.
[20] Cavalieri, E. L.; Stack, D. E.; Devanesan, P. D.; Todorovic, R.; Dwivedy, I.;
Higginbotham, S.; Johansson, S. L.; Patil, K. D.; Gross, M. L.; Gooden, J. K.;
Ramanathan, R.; Cerny, R. L.; Rogan, E. G. Molecular origin of cancer: catechol
estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. U. S. A.
94:10937–10942; 1997.
[21] Li, K. M.; Todorovic, R.; Devanesan, P.; Higginbotham, S.; Kofeler, H.; Ramanathan,
R.; Gross, M. L.; Rogan, E. G.; Cavalieri, E. L. Metabolism and DNA binding studies of
4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat
mammary gland in vivo. Carcinogenesis 25:289–297; 2004.
Acknowledgments
This research was supported by Grants P01 CA49210 from the
National Cancer Institute and DAMD17-03-10229 from the Depart-
ment of Defense Breast Cancer Research Program and by Prevention
LLC. Core support at the Eppley Institute was provided by Grant P30
CA36727 from the National Cancer Institute.
[22] Zahid, M.; Kohli, E.; Saeed, M.; Rogan, E.; Cavalieri, E. The greater reactivity of
estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of
depurinating adducts: implications for tumor-initiating activity. Chem. Res.
Toxicol. 19:164–172; 2006.